COMP <GO>
INSM vs ROIV // EV/EBITDA & P/E VALUATION
Insmed Incorporated (NASDAQ) VS. Roivant Sciences Ltd. (NASDAQ) • 15-METRIC TALLY: INSM 5
— ROIV 4
■ METRIC PARITY
LAST: $112.58 (+0.89%) • MKT CAP: $24.37B
valuation
—
LAST: $36.91 (-1.63%) • MKT CAP: $27.10B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INSM VS. ROIV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INSM | ROIV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 79.70% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -14.00% | -21.00 | ROIV | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.97% | -2.80% | -1.17 | ROIV | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 66.70% | -65.00% | +131.70 | INSM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.25 | 26.00 | -20.75 | ROIV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 3/9 | +2.00 | INSM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.0 | 57.2 | +3.80 | INSM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.03 | 1.00 | +0.03 | INSM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 28.0x | -7.00 | INSM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $24.37B | $27.10B | -$2.73B | ROIV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INSM REV | ROIV REV | INSM GROSS % | ROIV GROSS % | INSM FCF | ROIV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $606.4M | $8.3M | 79.7% | — | -$967.6M | -$758.6M |
| FY 2024 | $363.7M | $29.1M | 76.4% | — | -$705.8M | -$844.0M |
| FY 2023 | $305.2M | $32.7M | — | — | -$550.0M | -$766.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INSM // BETA 1.03
ROIV // BETA 1.00